Over a week after AstraZeneca announced a global withdrawal of its vaccine against coronavirus citing a slowdown in sales and availability of enough options in the market, new research has linked it to a rare disorder. Researchers found that the AstraZeneca vaccine, sold in India under the brand name Covishield, is linked to a rare blood clotting disorder called Vaccine-Induced …
The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors …
